Altris and Ligna Develops the World’s First Ultrathin Sodium-Ion Battery

Altris, together with Swedish partners Ligna, Jemac and RISE and with funding from Vinnova, is developing what it calls the world’s first ultrathin sodium‑ion battery—designed and manufactured entirely in Sweden for next‑generation connected electronics such as wearables and IoT. The project pairs Altris’s industrialised sodium‑ion cathode technology with Ligna’s roll‑to‑roll thin‑cell manufacturing, Jemac’s hardware integration and RISE’s testing and validation to move the concept toward commercial reality. The collaboration is pitched as a way to deliver safer, more sustainable small‑format batteries while strengthening Europe’s domestic battery value chain and reducing reliance on imported materials.

Analysis

Altris, together with Swedish partners Ligna, Jemac and RISE and with funding support from Vinnova, is developing what it describes as the world’s first ultrathin sodium‑ion battery, with development and production claimed to be entirely in Sweden. The project explicitly combines Altris’ industrialised sodium‑ion cathode technology, Ligna’s roll‑to‑roll thin‑cell manufacturing, Jemac’s hardware integration and RISE’s testing and validation to move the concept from idea toward commercial reality.

The initiative targets next‑generation connected electronics such as wearables and IoT and is positioned as a safer, more sustainable small‑format alternative that reduces Europe’s dependence on imported battery materials. The external signals rate sentiment as mildly positive (0.3) and market impact as modest (0.25), indicating strategic importance for European supply‑chain resilience but limited immediate disruption to global battery markets.

Key implications are strengthened domestic value‑chain coordination and a technology diversification away from lithium chemistry, but material risks remain: timelines and scalability are unspecified, commercial performance versus incumbent lithium‑ion cells is unproven, and broader adoption depends on manufacturing scale‑up and validation results from RISE and partners. Investors should therefore treat this as an early‑stage, strategically important technology play that requires milestone monitoring before altering position size.

Key Decisions for Investors

• Monitor concrete commercialization milestones (pilot production metrics from Ligna, cell performance and validation results from RISE, and integration tests from Jemac) before increasing exposure
• Favor selective, modest exposure to suppliers or partners that can benefit from localized manufacturing and ESG narratives while avoiding broad sector allocations until scale and performance are demonstrated
• Use announcements of successful scale‑up, additional Vinnova or private funding, or product qualification in wearables/IoT as buy triggers and treat timeline slips or negative validation results as sell or hedge triggers